GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
Compound class:
Synthetic organic
Comment: JH-LPH-33 is an analogue of AZ1 and optimized lead from a series of sulfonyl piperazine compounds that inhibit UDP-2,3-diacylglucosamine hydrolase (LpxH), an essential enzyme in the lipopolysaccharide synthesis pathway of bacteria [1]. LpxH is conserved in the majority of Gram-negative bacteria but absent in human, and is an attractive target for antibacterial development.
|
|
Bioactivity Comments |
JH-LPH-33 has activity against Gram-negative bacteria in vitro, demonstrating improved activity against Klebsiella pneumoniae and Escherichia coli (when coadministered with outer membrane permeability enhancers) compared to AZ1 [1]. JH-LPH-33 inhibits LpxH more potently than AZ1, with IC50 values of 0.026 μM against K. pneumoniae LpxH and 0.046 μM against E. coli LpxH [1]. |